Senior Research Associate, Gene Therapy
Insmed Incorporated
Summary
We're looking for a Senior Research Associate on the Gene Therapy Research Team to help us expand what's possible for patients with serious diseases. Reporting to the Executive Director, Gene Therapy, you'll be responsible for design and development of droplet digital PCR (ddPCR) assays, quantitating DNA and mRNA both in vitro and from in vivo samples. Additionally, you will document methods and studies and participate in the technical transfer of assays to third party contractors. Depending on experience, you will expand molecular and product specific assay development working with the analytical development team.
Job description
About the Role
We're looking for a Senior Research Associate on the Gene Therapy Research Team to help us expand what's possible for patients with serious diseases. Reporting to the Executive Director, Gene Therapy, you'll be responsible for design and development of droplet digital PCR (ddPCR) assays, quantitating DNA and mRNA both in vitro and from in vivo samples. Additionally, you will document methods and studies and participate in the technical transfer of assays to third party contractors. Depending on experience, you will expand molecular and product specific assay development working with the analytical development team.
What You'll Do
- Master and execute ddPCR assays developed in partnership with supervisor
- Follow protocols and SOPs related to ddPCR lab work with in vitro and in vivo samples
- Extract DNA and RNA from samples for analysis
- Document results in appropriate formats provided by supervisor
Basic Qualifications
You meet one of the following minimum education and experience requirements: Master's degree; OR Bachelor's degree and 1 year of experience in droplet digital PCR (ddPCR).
Preferred Qualifications
- Bachelor's degree in biology, Chemistry, or related field. Graduate degree holders are encouraged to apply
- Significant and demonstrated experience in operation of BioRad ddPCR equipment (QX200), as well as assay development, optimization, and interpretation
- General cellular and molecular biology proficiency
- Western blot, cloning, general mammalian cell culture, and transfection
- Excellent communication skills with ability to interact professionally with colleagues and present research results in written reports and team presentations
- Willingness to learn new techniques and train other laboratory staff in technical matters
- Entrepreneurial spirit, with strong willingness to take on new challenges required to bring novel medicines to the clinic
- Strict adherence to environmental, health, and safety guidelines
Requirements
- Master's degree; OR Bachelor's degree and 1 year of experience in droplet digital PCR (ddPCR)
- Bachelor's degree in biology, Chemistry, or related field
- Experience operating BioRad ddPCR equipment (QX200)
- Assay development, optimization, and interpretation experience
- General cellular and molecular biology proficiency
- Western blot, cloning, mammalian cell culture, and transfection
- Excellent communication skills
- Strict adherence to environmental, health, and safety guidelines
Benefits
- Medical, Dental & Vision
- Mental Health Support
- Wellbeing Reimbursement
- Employee Assistance Program
- Paid Time Off
- Fertility Benefits
- Family-Forming Benefits
- Caregiver Support
- Flexible Work Schedules
- 401(k) Matching
- Annual Equity Awards
- Employee Stock Purchase Plan
- Life Insurance
- Disability Insurance
- LinkedIn Learning
- Skill Building Workshops
- Leadership Programs
- Mentorship Connections
Company overview
Insmed Incorporated is a people-first global biopharmaceutical company dedicated to transforming the lives of patients with serious and rare diseases. Headquartered in Bridgewater, New Jersey, with offices and research locations throughout the United States, Europe, and Japan, the company focuses on delivering first- and best-in-class therapies for underserved patient communities. Insmed's portfolio includes two approved therapies for chronic lung diseases: ARIKAYCE for Mycobacterium avium complex lung disease and BRINSUPRI for non-cystic fibrosis bronchiectasis. The company is advancing a diverse pipeline of mid- to late-stage investigational medicines and cutting-edge drug discovery programs spanning gene therapy, AI-driven protein engineering, RNA end-joining, and synthetic rescue technologies. Recognized as the No. 1 Science Top Employer for five consecutive years, Insmed employs 1,001-5,000 professionals globally and maintains a strong commitment to innovation, patient-centricity, and corporate responsibility.